Molecular genetic overlap between migraine and major depressive disorder
- PMID: 29995844
- PMCID: PMC6057914
- DOI: 10.1038/s41431-018-0150-2
Molecular genetic overlap between migraine and major depressive disorder
Abstract
Migraine and major depressive disorder (MDD) are common brain disorders that frequently co-occur. Despite epidemiological evidence that migraine and MDD share a genetic basis, their overlap at the molecular genetic level has not been thoroughly investigated. Using single-nucleotide polymorphism (SNP) and gene-based analysis of genome-wide association study (GWAS) genotype data, we found significant genetic overlap across the two disorders. LD Score regression revealed a significant SNP-based heritability for both migraine (h2 = 12%) and MDD (h2 = 19%), and a significant cross-disorder genetic correlation (rG = 0.25; P = 0.04). Meta-analysis of results for 8,045,569 SNPs from a migraine GWAS (comprising 30,465 migraine cases and 143,147 control samples) and the top 10,000 SNPs from a MDD GWAS (comprising 75,607 MDD cases and 231,747 healthy controls), implicated three SNPs (rs146377178, rs672931, and rs11858956) with novel genome-wide significant association (PSNP ≤ 5 × 10-8) to migraine and MDD. Moreover, gene-based association analyses revealed significant enrichment of genes nominally associated (Pgene-based ≤ 0.05) with both migraine and MDD (Pbinomial-test = 0.001). Combining results across migraine and MDD, two genes, ANKDD1B and KCNK5, produced Fisher's combined gene-based P values that surpassed the genome-wide significance threshold (PFisher's-combined ≤ 3.6 × 10-6). Pathway analysis of genes with PFisher's-combined ≤ 1 × 10-3 suggested several pathways, foremost neural-related pathways of signalling and ion channel regulation, to be involved in migraine and MDD aetiology. In conclusion, our study provides strong molecular genetic support for shared genetically determined biological mechanisms underlying migraine and MDD.
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
- Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537–542. - PubMed
-
- Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Prevalence of depression and utilization of health care in single and multiple morbidity: a population-based cohort study. Psychol Med. 2013;43:1423–1431. - PubMed
-
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095–3105. - PubMed
-
- Breslau N, Davis GC, Schultz LR, Peterson EL. Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache. 1994;34:387–393. - PubMed
-
- Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308–1312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA007535/AA/NIAAA NIH HHS/United States
- R01 MH066206/MH/NIMH NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- R01 AA013321/AA/NIAAA NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- R01 AA013320/AA/NIAAA NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- R01 AA013326/AA/NIAAA NIH HHS/United States
- MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom
- R56 DA012854/DA/NIDA NIH HHS/United States
- R01 AA010249/AA/NIAAA NIH HHS/United States
- K08 DA019951/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
